Rontis invests €180M in Greek pharma expansion, new Kozani unit

Greek pharmaceutical firm Rontis announced a €180M investment program including expansion in Larissa and a new production unit in Kozani. The move signals domestic manufacturing capacity growth, though details on funding and timeline remain unspecified. It matters as a notable regional industrial investment in Greece's pharma sector.